WASSON GREGORY D has filed 15 insider transactions across 2 companies since December 2022.
Most recent transaction: a grant/award of 2000 shares of P3 Health Partners Inc. ($PIII) on August 06, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 6, 2025 | P3 Health Partners Inc. | $PIII | WASSON GREGORY D | Director | A | Class A Common Stock | 2000 | $0.00 | 23,523.0000 | 358,827,000 | 9.29% | 0.00% |
| Aug. 6, 2025 | P3 Health Partners Inc. | $PIII | WASSON GREGORY D | Director | A | Class A Common Stock | 2000 | $0.00 | 218,561.0000 | 358,827,000 | 0.92% | 0.00% |
| June 11, 2025 | OptimizeRx Corp | $OPRX | WASSON GREGORY D | Director | A | Common Stock | 9868 | $0.00 | 57,183.0000 | 20,234,186 | 20.86% | 0.05% |
| June 5, 2024 | OptimizeRx Corp | $OPRX | WASSON GREGORY D | Director | M | Common Stock | 10061 | $0.00 | 34,029.0000 | 19,921,879 | 41.98% | 0.05% |
| June 7, 2024 | OptimizeRx Corp | $OPRX | WASSON GREGORY D | Director | A | Common Stock | 13286 | $0.00 | 47,315.0000 | 19,921,879 | 39.04% | 0.07% |
| June 5, 2024 | OptimizeRx Corp | $OPRX | WASSON GREGORY D | Director | M | Restricted Stock Units | 10061 | $0.00 | 0.0000 | 19,921,879 | 100.00% | 0.05% |
| June 6, 2024 | P3 Health Partners Inc. | $PIII | WASSON GREGORY D | Director | A | Stock Option (Right to Buy) | 482640 | $0.00 | 482,640.0000 | 313,157,000 | 9999.99% | 0.15% |
| Oct. 23, 2023 | P3 Health Partners Inc. | $PIII | WASSON GREGORY D | Director | A | Class A Common Stock | 216561 | $0.00 | 1,076,209.0000 | 0 | 25.19% | 0.00% |
| June 7, 2023 | OptimizeRx Corp | $OPRX | WASSON GREGORY D | Director | A | Restricted Stock Units | 10061 | $0.00 | 10,061.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | OptimizeRx Corp | $OPRX | WASSON GREGORY D | Director | M | Restricted Stock Units | 4637 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 7, 2023 | OptimizeRx Corp | $OPRX | WASSON GREGORY D | Director | M | Common Stock | 4637 | $0.00 | 23,968.0000 | 0 | 23.99% | 0.00% |
| March 31, 2023 | OptimizeRx Corp | $OPRX | WASSON GREGORY D | Director | M | Common Stock | 657 | $0.00 | 19,331.0000 | 0 | 3.52% | 0.00% |
| March 31, 2023 | OptimizeRx Corp | $OPRX | WASSON GREGORY D | Director | M | Restricted Stock Units | 657 | $0.00 | 657.0000 | 0 | 50.00% | 0.00% |
| Dec. 30, 2022 | OptimizeRx Corp | $OPRX | WASSON GREGORY D | Director | M | Common Stock | 409 | $0.00 | 18,674.0000 | 0 | 2.24% | 0.00% |
| Dec. 30, 2022 | OptimizeRx Corp | $OPRX | WASSON GREGORY D | Director | M | Restricted Stock Units | 409 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |